NCI is the nation's leader in cancer research
Through this effort, NCI is launching new initiatives to achieve bold new goals that will accelerate progress against cancer.
Check out this directory of NCI-supported tools and services for cancer researchers.
NCI is mobilizing its experts and resources to study COVID-19.
Progress against cancer requires long-term investments in basic research, as illustrated by the story of how the targeted cancer drug crizotinib was developed.
Read about major research initiatives NCI has developed to address high-priority issues for the cancer research community.
